Over the past 12 months, 5 insiders at EXACT SCIENCES CORP filed 8 open-market SEC Form 4 transactions on EXAS: 0 purchases worth $0 and 8 sales worth $1.8M. Insiders have been net sellers over this period. The most recent filing was on Nov 19, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 19, 25 | James HerriottSVP, General Counsel & Sec | SELL | 1.0K | $70.00 | $70K |
| Nov 19, 25 | Jacob A OrvilleEVP, GM, Screening | SELL | 5.0K | $75.00 | $375K |
| Nov 4, 25 | Brian BaranickEVP, GM, Precision Oncology | SELL | 2.9K | $70.08 | $200K |
| Nov 4, 25 | James HerriottSVP, General Counsel & Sec | SELL | 1.5K | $70.08 | $105K |
| Oct 24, 25 | Katherine S ZanottiDirector | SELL | 12.0K | $65.00 | $780K |
| Oct 9, 25 | James Edward DoyleDirector | SELL | 2.0K | $60.00 | $120K |
| Oct 9, 25 | James HerriottSVP, General Counsel & Sec | SELL | 1.5K | $60.00 | $90K |
| Aug 13, 25 | James Edward DoyleDirector | SELL | 1.5K | $42.02 | $62K |
| Jun 13, 25 | Katherine S ZanottiDirector | SELL | 3.2K | $53.20 | $171K |
| Nov 13, 24 | Kevin T ConroyPresident and CEO | BUY | 19.5K | $51.35 | $1.0M |
| Oct 8, 24 | Brian BaranickEVP, GM, Precision Oncology | SELL | 929 | $70.00 | $65K |
| Sep 18, 24 | Brian BaranickEVP, GM, Precision Oncology | SELL | 929 | $70.00 | $65K |
| May 1, 24 | Brian BaranickEVP, GM., Precision Oncology | SELL | 110 | $60.15 | $7K |
| May 1, 24 | D Scott CowardDirector | SELL | 67 | $60.15 | $4K |
| May 1, 24 | Sarah CondellaEVP, Human Resources | SELL | 102 | $60.15 | $6K |
| May 1, 24 | Kevin T ConroyPresident and CEO | SELL | 1.2K | $60.15 | $69K |
| May 1, 24 | Everett CunninghamChief Commercial Officer | SELL | 136 | $60.15 | $8K |
| May 1, 24 | Jeffrey Thomas ElliottChief Financial Officer | SELL | 136 | $60.15 | $8K |
| May 1, 24 | James HerriottSVP, General Counsel & Sec | SELL | 30 | $60.15 | $2K |
| May 1, 24 | Jacob A OrvilleGeneral Manager, Screening | SELL | 102 | $60.15 | $6K |
| Apr 2, 24 | Brian BaranickEVP, GM., Precision Oncology | SELL | 924 | $79.43 | $73K |
| Apr 1, 24 | Sarah CondellaEVP, Human Resources | SELL | 2.0K | $70.00 | $140K |
| Mar 28, 24 | Sarah CondellaEVP, Human Resources | SELL | 2.0K | $70.00 | $140K |
| Mar 1, 24 | James Edward DoyleDirector | SELL | 2.0K | $57.50 | $115K |
| Mar 1, 24 | Daniel J LevangieDirector | SELL | 5.0K | $57.50 | $288K |
| Mar 1, 24 | Brian BaranickGen. Mgr., Precision Oncology | SELL | 2.3K | $59.32 | $138K |
| Mar 1, 24 | Sarah CondellaEVP, Human Resources | SELL | 1.7K | $59.32 | $102K |
| Mar 1, 24 | Kevin T ConroyPresident and CEO | SELL | 8.3K | $59.32 | $491K |
| Mar 1, 24 | Everett CunninghamChief Commercial Officer | SELL | 2.4K | $59.32 | $143K |
| Mar 1, 24 | Jeffrey Thomas ElliottChief Financial Officer | SELL | 2.4K | $59.32 | $143K |
| Mar 1, 24 | James HerriottGeneral Counsel | SELL | 862 | $59.32 | $51K |
| Mar 1, 24 | Jacob A OrvilleGeneral Manager, Screening | SELL | 2.2K | $59.32 | $128K |
| Feb 27, 24 | Brian BaranickGen. Mgr., Precision Oncology | SELL | 2.0K | $56.89 | $115K |
| Feb 27, 24 | Sarah CondellaEVP, Human Resources | SELL | 1.9K | $56.89 | $107K |
| Feb 27, 24 | Kevin T ConroyPresident and CEO | SELL | 6.3K | $56.89 | $356K |
| Feb 27, 24 | Everett CunninghamChief Commercial Officer | SELL | 3.6K | $56.89 | $208K |
| Feb 27, 24 | Jeffrey Thomas ElliottChief Financial Officer | SELL | 2.7K | $56.89 | $154K |
| Feb 27, 24 | James HerriottGeneral Counsel | SELL | 784 | $56.89 | $45K |
| Feb 27, 24 | Jacob A OrvilleGeneral Manager, Screening | SELL | 1.9K | $56.89 | $107K |
| Feb 23, 24 | Sarah CondellaEVP, Human Resources | SELL | 1.0K | $59.72 | $61K |
| Feb 22, 24 | Brian BaranickGen. Mgr., Precision Oncology | SELL | 1.1K | $59.78 | $65K |
| Feb 22, 24 | D Scott CowardDirector | SELL | 663 | $59.78 | $40K |
| Feb 22, 24 | Sarah CondellaEVP, Human Resources | SELL | 1.0K | $59.78 | $61K |
| Feb 22, 24 | Kevin T ConroyPresident and CEO | SELL | 11.6K | $59.78 | $691K |
| Feb 22, 24 | Everett CunninghamChief Commercial Officer | SELL | 1.4K | $59.78 | $81K |
| Feb 22, 24 | Jeffrey Thomas ElliottChief Financial Officer | SELL | 1.4K | $59.78 | $81K |
| Feb 22, 24 | James HerriottGeneral Counsel | SELL | 291 | $59.78 | $17K |
| Feb 22, 24 | Jacob A OrvilleGeneral Manager, Screening | SELL | 1.0K | $59.78 | $61K |
| Feb 21, 24 | Brian BaranickGen. Mgr., Precision Oncology | SELL | 895 | $61.50 | $55K |
| Feb 21, 24 | D Scott CowardDirector | SELL | 706 | $61.50 | $43K |
Over the past 12 months, insiders at EXACT SCIENCES CORP filed 0 open-market purchases worth $0 and 8 sales worth $1.8M on EXAS, which makes them net sellers over the period. The most recent Form 4 was filed on Nov 19, 25.
The largest recent open-market EXAS insider purchase in our data was $1.0M by Kevin T Conroy, President and CEO, filed on Nov 13, 24.
5 different insiders at EXACT SCIENCES CORP filed open-market SEC Form 4 transactions on EXAS over the last 12 months.
InsiderTape plots every EXAS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every EXACT SCIENCES CORP insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →